Serum CYR61 as a potential biomarker for the diagnosis of esophagogastric junction tumor

Background: Esophagogastric junction tumor (EGJ) is a rare but fatal disease with a rapid rising incidence worldwide in the late 20 years, and it lacks a convenient and safe method for diagnosis. The present study aimed to evaluate the potential of serum CYR61 as a biomarker for the diagnosis of EGJ...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Ling-Yu, Zhou, Jian-Yuan, Zhao, Yi-Xuan, Ou, Yan-Ting, Yang, Tian, Peng, Yu-Hui, Fang, Wang-Kai, Xu, Yi-Wei, Xie, Jian-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2021
Materias:
Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217984/
https://www.ncbi.nlm.nih.gov/pubmed/34085702
http://dx.doi.org/10.1042/BSR20204117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217984/
https://www.ncbi.nlm.nih.gov/pubmed/34085702
http://dx.doi.org/10.1042/BSR20204117

Ejemplares similares